Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04QUX
|
||||
Former ID |
DIB011713
|
||||
Drug Name |
PF-446687
|
||||
Synonyms |
PF-00446687; PF-2336652
|
||||
Indication | Female sexual dysfunction [ICD9: 302.7; ICD10:F52] | Phase 2 | [522609] | ||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@@H]1([C@@H](CN(C1)C(C)(C)C)c1ccc(cc1F)F)C(=O)N1C[C@H<br />]([C@](c2ccccc2)([C@H](C1)C)O)C.Cl
|
||||
Target and Pathway | |||||
Target(s) | Melanocortin-4 receptor | Target Info | Modulator | [533131] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Pathway Interaction Database | Syndecan-3-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.